DNA Hypomethylation Silences Anti-Tumor Immune Genes in Early Prostate Cancer and CTCs

Through high-resolution genome-wide single-cell DNA methylation sequencing, scientists identified 40 core domains that were uniformly hypomethylated from the earliest detectable stages of prostate malignancy through metastatic circulating tumor cells.